Literature DB >> 22827214

Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.

Molykutty John-Aryankalayil1, Sanjeewani T Palayoor, Adeola Y Makinde, David Cerna, Charles B Simone, Michael T Falduto, Scott R Magnuson, C Norman Coleman.   

Abstract

We have previously demonstrated that prostate carcinoma cells exposed to fractionated radiation differentially expressed more genes compared to single-dose radiation. To understand the role of miRNA in regulation of radiation-induced gene expression, we analyzed miRNA expression in LNCaP, PC3 and DU145 prostate cancer cells treated with single-dose radiation and fractionated radiation by microarray. Selected miRNAs were studied in RWPE-1 normal prostate epithelial cells by RT-PCR. Fractionated radiation significantly altered more miRNAs as compared to single-dose radiation. Downregulation of oncomiR-17-92 cluster was observed only in the p53 positive LNCaP and RWPE-1 cells treated with single-dose radiation and fractionated radiation. Comparison of miRNA and mRNA data by IPA target filter analysis revealed an inverse correlation between miR-17-92 cluster and several targets including TP53INP1 in p53 signaling pathway. The base level expressions of these miRNAs were significantly different among the cell lines and did not predict the radiation outcome. Tumor suppressor miR-34a and let-7 miRNAs were upregulated by fractionated radiation in radiosensitive LNCaP (p53 positive) and PC3 (p53-null) cells indicating that radiation-induced miRNA expression may not be regulated by p53 alone. Our data support the potential for using fractionated radiation to induce molecular targets and radiation-induced miRNAs may have a significant role in predicting radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22827214      PMCID: PMC4156966          DOI: 10.1667/rr2703.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  58 in total

1.  MicroRNA expression after ionizing radiation in human endothelial cells.

Authors:  Mechthild Wagner-Ecker; Christian Schwager; Ute Wirkner; Amir Abdollahi; Peter E Huber
Journal:  Radiat Oncol       Date:  2010-03-26       Impact factor: 3.481

2.  Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.

Authors:  Xinrong Chen; Jian Yan; Tao Chen
Journal:  Mol Carcinog       Date:  2011-08-01       Impact factor: 4.784

3.  Computer programs for the analysis of cellular survival data.

Authors:  N Albright
Journal:  Radiat Res       Date:  1987-11       Impact factor: 2.841

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

6.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

Authors:  Qingchuan Dong; Ping Meng; Tao Wang; Weiwei Qin; Weijun Qin; Fuli Wang; Jianlin Yuan; Zhinan Chen; Angang Yang; He Wang
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

10.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

View more
  39 in total

1.  mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status.

Authors:  Charles B Simone; Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Transl Oncol       Date:  2013-10-01       Impact factor: 4.243

Review 2.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

3.  The Radiation Stress Response: Of the People, By the People and For the People.

Authors:  C Norman Coleman
Journal:  Radiat Res       Date:  2017-01-24       Impact factor: 2.841

4.  The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster.

Authors:  Lianjin Jin; Meng Lim; Shuping Zhao; Yuri Sano; Brittany A Simone; Jason E Savage; Eric Wickstrom; Kevin Camphausen; Richard G Pestell; Nicole L Simone
Journal:  Breast Cancer Res Treat       Date:  2014-05-27       Impact factor: 4.872

5.  Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer.

Authors:  Sujuan Feng; Xiaosong Qian; Han Li; Xiaodong Zhang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

6.  Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Authors:  Deborah E Citrin; Pataje G S Prasanna; Amanda J Walker; Michael L Freeman; Iris Eke; Mary Helen Barcellos-Hoff; Molykutty J Arankalayil; Eric P Cohen; Ruth C Wilkins; Mansoor M Ahmed; Mitchell S Anscher; Benjamin Movsas; Jeffrey C Buchsbaum; Marc S Mendonca; Thomas A Wynn; C Norman Coleman
Journal:  Radiat Res       Date:  2017-05-10       Impact factor: 2.841

7.  Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

Authors:  Mansoor M Ahmed; C Norman Coleman; Marc Mendonca; Soren Bentzen; Bhadrasain Vikram; Stephen M Seltzer; Dudley Goodhead; Ceferino Obcemea; Radhe Mohan; Kevin M Prise; Jacek Capala; Deborah Citrin; Gary Kao; Molykutty Aryankalayil; Iris Eke; Jeffrey C Buchsbaum; Pataje G S Prasanna; Fei-Fei Liu; Quynh-Thu Le; Beverly Teicher; David G Kirsch; DeeDee Smart; Joel Tepper; Silvia Formenti; Daphne Haas-Kogan; David Raben; James Mitchell
Journal:  Cancer Res       Date:  2018-04-23       Impact factor: 12.701

8.  Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation.

Authors:  Sanjeewani T Palayoor; Molykutty John-Aryankalayil; Adeola Y Makinde; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Mol Cancer Res       Date:  2014-04-30       Impact factor: 5.852

Review 9.  Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.

Authors:  Adeola Y Makinde; Iris Eke; Molykutty J Aryankalayil; Mansoor M Ahmed; C Norman Coleman
Journal:  Semin Radiat Oncol       Date:  2016-07-05       Impact factor: 5.934

10.  Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.

Authors:  Molykutty J Aryankalayil; Adeola Y Makinde; Sofia R Gameiro; James W Hodge; Patricia P Rivera-Solis; Sanjeewani T Palayoor; Mansoor M Ahmed; C Norman Coleman
Journal:  Radiat Res       Date:  2014-07-08       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.